Subbu Nambi
Stock Analyst at Guggenheim
(2.18)
# 2,739
Out of 4,876 analysts
38
Total ratings
46.43%
Success rate
-3.02%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Buy | $122 → $114 | $94.79 | +20.27% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $35.93 | +39.16% | 2 | May 6, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $198.80 | +25.75% | 1 | Apr 23, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $7.41 | +34.95% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $53.65 | +11.84% | 2 | Apr 11, 2025 | |
| NEOG Neogen | Maintains: Buy | $15 → $13 | $4.73 | +174.84% | 2 | Apr 10, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $5.25 | - | 2 | Apr 9, 2025 | |
| VCYT Veracyte | Maintains: Buy | $45 → $37 | $27.38 | +35.14% | 3 | Apr 9, 2025 | |
| TEM Tempus AI | Reiterates: Buy | n/a | $66.52 | - | 2 | Feb 25, 2025 | |
| BRKR Bruker | Reiterates: Buy | n/a | $41.80 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $50.86 | +10.11% | 5 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $167.96 | +19.08% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $48.39 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.09 | +94.17% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.69 | +764.93% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.73 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $123.56 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $20.35 | +22.85% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.29 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.24 | - | 1 | Dec 14, 2023 |
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $94.79
Upside: +20.27%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $35.93
Upside: +39.16%
Danaher
Apr 23, 2025
Reiterates: Buy
Price Target: $250
Current: $198.80
Upside: +25.75%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $7.41
Upside: +34.95%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $53.65
Upside: +11.84%
Neogen
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $4.73
Upside: +174.84%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.25
Upside: -
Veracyte
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $27.38
Upside: +35.14%
Tempus AI
Feb 25, 2025
Reiterates: Buy
Price Target: n/a
Current: $66.52
Upside: -
Bruker
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $41.80
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $50.86
Upside: +10.11%
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $167.96
Upside: +19.08%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $48.39
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.09
Upside: +94.17%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.69
Upside: +764.93%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $11.73
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $123.56
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $20.35
Upside: +22.85%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.24
Upside: -